Drug intelligence / Profile preview

[(2-amino-alpha-methoxyimino-4-thiazolylacetyl)amino]methylboronic acid

Development stage
Unknown
Modality
Small Molecules
01

Overview

This compound is a small molecule belonging to the class of boronic acids and 2,4-disubstituted thiazoles. It contains a thiazole ring and a boronic acid moiety. It acts as an inhibitor of beta-lactamase TEM enzymes, which are bacterial enzymes responsible for antibiotic resistance by hydrolyzing beta-lactam antibiotics. By inhibiting these enzymes, it can potentially restore the efficacy of beta-lactam antibiotics against resistant bacteria. The compound is experimental and has not been approved for clinical use or indicated for any specific conditions. Its molecular formula is C7H11BN4O4S with an average molecular weight of approximately 258 Da[1][5].

Other names
{[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]methyl}boronic acidBoronic acid, B-[[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)-1-oxoethyl]amino]methyl]-CEFOTAXIME BATSI
02

Targets

CD248 (Endosialin)

Beyond the preview

Go deeper on [(2-amino-alpha-methoxyimino-4-thiazolylacetyl)amino]methylboronic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on [(2-amino-alpha-methoxyimino-4-thiazolylacetyl)amino]methylboronic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call